Last reviewed · How we verify
NCT03867461
The Effects of MAP and EtCO2 on Venous Sinus Pressures
NA trial testing Venous Sinus Stenting in Idiopathic Intracranial Hypertension in 8 participants. Completed in 25 September 2019.
25 September 2019
Quick facts
| Lead sponsor | Wake Forest University Health Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 8 |
| Start date | 20 June 2019 |
| Primary completion | 25 September 2019 |
| Estimated completion | 25 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Venous Sinus Stenting
- Adjustment to end-tidal carbon dioxide concentrations ( 38-40 mmHg range)
- Adjustment to Mean Arterial Pressure (100-110 mmHg range)
- Adjustment to Mean Arterial Pressure (60-80 mmHg range)
- Adjustment to end-tidal carbon dioxide concentrations (24-26 mmHg range)
Conditions studied
- Idiopathic Intracranial Hypertension — all drugs for Idiopathic Intracranial Hypertension →
Sponsor
Wake Forest University Health Sciences
Who can join
18 and older, any sex, with Idiopathic Intracranial Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to further elaborate the role of both arterial blood pressure and end-tidal carbon dioxide concentration on measured venous pressures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03867461
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Idiopathic Intracranial Hypertension
Currently open trials in the same condition.
- NCT06855342 — Prospective Ocular Imaging for Intracranial Pressure Evaluation · recruiting
- NCT06545981 — Ocular Perfusion in Patients With Idiopathic Intracranial Hypertension · recruiting
- NCT06059703 — Biomarkers in the Etiology of Idiopathic Intracranial Hypertension · NA · recruiting
- NCT03556085 — Venous Sinus Stenting With the River Stent in IIH · NA · active not recruiting
- NCT03096743 — Evaluating Raised Intracranial Pressure Using MR Elastography · NA · active not recruiting
Other Wake Forest University Health Sciences trials
Trials by the same sponsor.
- NCT07474090 — Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · NA · not yet recruiting
- NCT07282444 — A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial · NA · not yet recruiting
- NCT06876896 — Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter · NA · recruiting
- NCT07227051 — Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity · NA · recruiting
- NCT07215624 — Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03867461 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wake Forest University Health Sciences
- Last refreshed: 12 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03867461.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing